Skip to main content

Table 5 Exclusion criteria

From: Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend

Exclusion criteria Notes
Null entries No information is reported in title and abstract fields
Duplicates Duplicate of an existing entry
Not in the language of interest English only
Abstract that is reported elsewhere A conference abstract with the content reported in another publication
Not study type of interest Not a cost-effectiveness analysis
Not HPV vaccination Not including an arm of HPV vaccination ± screening
Not the country of interest Countries of interest include: Austria, Belgium, Switzerland, Czech Republic, Germany, Denmark, Spain, Finland, France, Greece, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Sweden, Slovenia, and the UK, the US, Canada and Australia
No outcome of interest Health economic endpoints